The majority of materials we rely on in our built environment come from chemicals derived from petroleum (petrochemicals), ...

LP-184 has also shown promise in cancers with DNA damage response deficiencies beyond deficiencies in homologous recombination ... including both solid tumors and blood cancers and an antibody-drug ...

2024 年第 47 届 圣安东尼奥乳腺癌研讨会（San Antonio Breast Cancer Symposium，SABCS）将于 2024 年 12 月 10-13 日在美国圣安东尼奥隆重召开。SABCS ...

Lonza has continued to adapt to the evolving ADC landscape, including the recent addition of a highly potent vial fill ...

Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studiesCollaboration underscores Lonza's commitment to helping customers deliver ...

Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies Collaboration underscores ...

Bacteria in our intestines engage in genetic exchanges, called bacterial conjugation, and sometimes this gene swapping ...

VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug and diagnostics discovery, and Fina Biosolutions LLC (FinaBio), experts in ...

The company will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site.

This valuable paper shows image correlation spectroscopy (ICS) as a new tool to analyze the clustering of proteins involved in DNA damage response (DDR). The solid evidence presented demonstrates that ...

You can edit what information becomes public or private on the site, and how you want to appear to other users if your DNA matches with someone else. You'll have an opportunity to review all ...